Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia-inducible factors (HIFs) are a family of transcription factors that play a central role in cellular adaptation to low oxygen (hypoxic) conditions. They regulate the expression of genes involved in processes such as angiogenesis, erythropoiesis, metabolism, and cell survival under hypoxic stress. HIFs function as heterodimers composed of an oxygen-sensitive alpha subunit (HIF-1α, HIF-2α, and HIF-3α) and a constitutively expressed beta subunit (ARNT). Under normoxia, the alpha subunit is hydroxylated, leading to its degradation. Under hypoxia, hydroxylation is inhibited, the alpha subunit stabilizes, dimerizes with the beta subunit, and activates transcription of target genes.
Inhibition of HIF prolyl hydroxylation, disruption of HIF-VHL interaction, inhibition of HIF transcriptional activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia-Inducible Factor (None).